Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Considerations on the risk assessment of genetically modified plants containing transformation events stacked by conventional crossing.

EFSA journal. European Food Safety Authority·2026
Same author

Assessment of genetically modified soybean FG72 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2025-33580).

EFSA journal. European Food Safety Authority·2026
Same author

Tissue-embedded CD4<sup>+</sup> plasticity defines mucosal immunity in inflammatory bowel disease.

Mucosal immunology·2026
Same author

Aberrant intra-epithelial lymphocytes cause enterocyte cell death in refractory celiac disease by CD103-β7-receptor-mediated granzyme-B degranulation which can be restored by etrolizumab.

Clinical & translational immunology·2026
Same author

Novel genes associated with hypocretin-producing neurons identified by human gene expression profiling.

Journal of neuroimmunology·2026
Same author

Assessment of additional information related to genetically modified oilseed rape MS11 (application EFSA-GMO-BE-2016-138).

EFSA journal. European Food Safety Authority·2026

Related Experiment Video

Updated: Jun 10, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Celiac disease: how complicated can it get?

Jennifer May-Ling Tjon1, Jeroen van Bergen, Frits Koning

  • 1Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, RC Leiden, The Netherlands. j.m.l.tjon@lumc.nl

Immunogenetics
|July 28, 2010
PubMed
Summary

A proposed threshold model explains celiac disease development and complications. Gluten presentation efficiency, influenced by diet and genetics, determines disease likelihood and potential lymphoma risk in refractory patients.

More Related Videos

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Related Experiment Videos

Last Updated: Jun 10, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Area of Science:

  • Immunology
  • Gastroenterology
  • Genetics

Background:

  • Celiac disease involves an inflammatory response in the small intestine triggered by gluten proteins.
  • Most patients recover on a gluten-free diet, but some develop refractory celiac disease, potentially leading to lymphoma.
  • Celiac disease is strongly linked to HLA-DQ2 and/or HLA-DQ8 genotypes.

Purpose of the Study:

  • To propose a threshold model for celiac disease development.
  • To identify key factors influencing gluten presentation efficiency.
  • To understand the pathogenesis of refractory celiac disease and associated lymphoma.

Main Methods:

  • The study proposes a conceptual threshold model based on existing knowledge.
  • It analyzes factors affecting gluten peptide presentation to T cells.
  • It considers genetic predispositions and immune responses.

Main Results:

  • Gluten presentation efficiency to CD4(+) T cells is a critical determinant of celiac disease development and severity.
  • Factors influencing presentation include gluten intake, tissue transglutaminase 2 activity, HLA-DQ type and gene dose, and other genetic polymorphisms.
  • This model may elucidate the progression to refractory celiac disease and lymphoma.

Conclusions:

  • A threshold model integrating dietary, enzymatic, and genetic factors provides a framework for understanding celiac disease.
  • This model highlights the crucial role of gluten presentation in disease pathogenesis.
  • It offers insights into the development of refractory celiac disease and its malignant transformation.